Literature DB >> 16737946

Progress and opportunities in tobacco control.

Vilma Cokkinides1, Priti Bandi, Elizabeth Ward, Ahmedin Jemal, Michael Thun.   

Abstract

Much progress has been made in reducing tobacco use in the United States. Despite the continuing challenges of tobacco control and the massive burden of illness, death, and economic costs caused by tobacco products, there are now unprecedented opportunities to prevent and treat tobacco dependence through a combination of interventions that have proven effective at both the population and individual levels. This report briefly reviews population trends in tobacco use by youth and adults, describes some of the policy measures that have proven effective in comprehensive tobacco control, and discusses the role of clinicians in the diagnosis and treatment of tobacco dependence in patients.

Entities:  

Mesh:

Year:  2006        PMID: 16737946     DOI: 10.3322/canjclin.56.3.135

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  7 in total

1.  How do we safely get people to stop smoking?

Authors:  David C L Lam; John D Minna
Journal:  Cancer Prev Res (Phila)       Date:  2011-11

Review 2.  Developmental transitions to psychopathology: are there prodromes of substance use disorders?

Authors:  E Jane Costello; Adrian Angold
Journal:  J Child Psychol Psychiatry       Date:  2010-02-03       Impact factor: 8.982

3.  The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics.

Authors:  Ting-Yuan David Cheng; Susanna M Cramb; Peter D Baade; Danny R Youlden; Chukwumere Nwogu; Mary E Reid
Journal:  J Thorac Oncol       Date:  2016-06-27       Impact factor: 15.609

Review 4.  Facilitators and Barriers of Smokers' Compliance with Smoking Bans in Public Places: A Systematic Review of Quantitative and Qualitative Literature.

Authors:  Li Zhou; Lu Niu; Hui Jiang; Caixiao Jiang; Shuiyuan Xiao
Journal:  Int J Environ Res Public Health       Date:  2016-12-11       Impact factor: 3.390

Review 5.  Clinical utility of varenicline for smokers with medical and psychiatric comorbidity.

Authors:  Jon O Ebbert; Kirk D Wyatt; Ali Zirakzadeh; Michael V Burke; Jt Hays
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-11-29

6.  Patient complexity: more than comorbidity. the vector model of complexity.

Authors:  Monika M Safford; Jeroan J Allison; Catarina I Kiefe
Journal:  J Gen Intern Med       Date:  2007-12       Impact factor: 5.128

7.  Associations of social and material deprivation with tobacco, alcohol, and psychotropic drug use, and gender: a population-based study.

Authors:  Michèle Baumann; Elisabeth Spitz; Francis Guillemin; Jean-François Ravaud; Marie Choquet; Bruno Falissard; Nearkasen Chau
Journal:  Int J Health Geogr       Date:  2007-11-09       Impact factor: 3.918

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.